Options after a final rejection

When an action is final, and when it should not be

Under MPEP 706.07(a), the second or any later action on the merits is made final, except where the examiner introduces a new ground of rejection that was not necessitated by your amendment and not based on information in an IDS filed with the 37 CFR 1.17(p) fee during the 1.97(c) window. Read the final action against your last reply. If a new reference appears against a claim you did not amend, the finality may be premature.

Raise that with the examiner first, in an interview or in your reply. If it is not withdrawn, the remedy is a petition under 37 CFR 1.181. It is not an appeal issue: MPEP 706.07(c) calls prematureness "purely a question of practice, wholly distinct from the tenability of the rejection," and the Board will not hear it. Keep running the reply clock while the petition is pending.

The clock after a final rejection

A final rejection sets a 3-month shortened period. If you file a complete first reply within 2 months, the period ends at 3 months or on the mailing date of the advisory action, whichever is later, and extension fees are counted from that later date (MPEP 706.07(f), 714.13). Miss the 2-month mark and extension fees run from 3 months regardless of when the advisory action arrives. Nothing extends the reply past 6 months from the final action.

The key trap: an after-final amendment that the examiner refuses to enter does not save the application (37 CFR 1.116(c)). If the advisory action says the claims are still rejected, you still need an RCE, a notice of appeal or a continuation before the period runs out. Extension fees at the standard rate are $235, $690 and $1,590 for the first three months (fee schedule).

Amendment after final and the advisory action

37 CFR 1.116(b) allows three kinds of amendment after final: cancelling claims or complying with a requirement of form already stated; amendments presenting rejected claims in better form for appeal, which "may be admitted"; and amendments touching the merits, only on a showing of good and sufficient reasons why they are necessary and were not presented earlier. Evidence such as a 1.132 declaration needs the same showing (1.116(e)).

In practice the examiner enters an amendment that "requires only a cursory review" (MPEP 714.13). Rewriting a dependent claim the examiner has called allowable into independent form, and cancelling the rest, is the classic example. Adding a limitation from the specification that needs a new search usually is not.

The examiner answers with an advisory action (form PTOL-303) or a notice of allowance. The USPTO publishes how this plays out. Over the 12 months to September 2026, its after final response dashboard counted 111,313 examiner actions in reply to after-final responses, with an average of 15 days and a median of 12 days to respond:

Source: USPTO Patents Dashboard, after final response data, report date September 2026. Smaller categories (appeal-related actions, abandonments, withdrawn actions) make up the remainder. The data counts all after-final replies, not only amendments.

So roughly three in ten after-final replies end in an allowance. That is the honest case for trying: it is cheap and quick. But two thirds come back as advisory actions, which leave you where you were, minus some time on the clock. File early, within the 2 months, so an unhelpful advisory action still leaves room for the next step.

The end of AFCP 2.0

The After Final Consideration Pilot 2.0 gave examiners extra time to search and consider a narrowing amendment after final, if the applicant asked for it and was willing to interview. The USPTO decided to let it expire. Its program page says December 14, 2024 was the last day to submit a request; requests filed after that are non-responsive, and the period for reply keeps running.

Much of the older advice online still tells applicants to "file an AFCP request." Ignore it. As of October 26, 2026 no replacement had been announced. A narrowing amendment that needs further search now goes in with an RCE, or is agreed in an interview first so it qualifies as needing only cursory review.

Interview after final

Under MPEP 713.09, an interview after final is normally granted once, where the examiner thinks the issues can be resolved with nominal further consideration. Use it to show a proposed amendment and ask a direct question: would this be entered, and would it be allowed? A yes turns the 1.116 amendment into a formality. A no tells you whether you are heading for an RCE (the examiner wants a different claim) or an appeal (the examiner reads the reference differently and will not move). Either way, file the reply within the 2-month window; an interview does not stop the clock.

Request for continued examination

An RCE under 37 CFR 1.114 withdraws the finality and gets your submission entered and considered. The submission must meet the reply requirements of 1.111 when a reply to the final action is outstanding; the fee alone does not stop the clock (MPEP 706.07(h)). Fees are $1,500 for the first RCE and $2,860 for each later one at the standard rate, $600 and $1,144 for small entities, $300 and $572 for micro entities.

The first action after an RCE can itself be final if all the claims could have been finally rejected on the grounds and art of record (MPEP 706.07(h), subsection VIII). An RCE is also excluded from the 3-year pendency guarantee in patent term adjustment. Both points, and when an RCE beats an appeal, are covered in our RCE guide. If speed matters, you can request prioritized examination with an RCE once per application (see Track One).

Pre-appeal brief conference

The pre-appeal brief conference program, running since July 2005, lets you ask a panel to review the rejection before you write an appeal brief (MPEP 1204.02). The request must be filed with the notice of appeal, on form PTO/AIA/33 or equivalent, with arguments of no more than 5 pages. It has no fee beyond the notice of appeal. No amendment may accompany it; a 1.116 amendment filed the same day disqualifies the request, and a non-compliant request cannot be fixed and refiled.

The panel includes at least a supervisor and the examiner of record. Since a September 2026 USPTO Official Gazette notice, a PTAB administrative patent judge may sit as a third panelist in an advisory role. That judge will not later sit on the Board panel deciding your appeal. The decision says the appeal proceeds, prosecution is reopened, the application is allowed, or the request is dismissed. The appeal brief is then due one month from the decision or within the rest of the 2 months from the notice of appeal, whichever is longer.

Outcomes, from the USPTO's dashboard for the 12 months reported in September 2026: 3,454 requests (67.8%) went on to the Board, 1,209 (23.7%) had prosecution reopened, and 432 (8.5%) were allowed. A reopening is not a win, since it usually brings a new rejection, but it often means the old one was weak.

Notice of appeal

Any applicant whose claims have been twice rejected may appeal by filing a notice of appeal with the $905 fee ($362 small, $181 micro) within the period for reply (37 CFR 41.31). The notice is a reply that keeps the application pending, and it buys time: the brief is due 2 months later, extendable under 1.136(a) (41.37). Amendments filed after the notice and before the brief are still judged under 1.116 (41.33(a)), and an RCE filed before a Board decision withdraws the appeal.

One cost to watch: filing the brief more than 3 months after the notice of appeal reduces patent term adjustment day for day (37 CFR 1.704(c)(11)). The full process, fees and Board statistics are in our PTAB ex parte appeal guide. In brief: in FY 2026 the Board fully affirmed 59.8% of decided appeals, affirmed in part 8.0% and reversed 31.5%, and decisions from July to September 2026 averaged 5.9 months from Board receipt (PTAB statistics).

Continuation

A continuation filed while the parent is pending keeps the parent's filing date and lets you split the fight. If the final action allows some claims, you can amend the parent down to those claims, take the patent, and pursue the broader claims in the continuation. A continuation carries new filing, search and examination fees ($2,000 standard before excess claims), and the 37 CFR 1.17(w) continuing application fee if it is filed more than six years after the earliest benefit date. It does not carry the 35 U.S.C. 121 shield that a divisional gets; see restriction requirements.

Decision table: costs and timing

Fees are standard / small / micro unless marked, from the USPTO fee schedule effective January 19, 2025 (last revised August 14, 2026). Attorney time is extra and usually larger than the official fee.

Worked example

A small entity receives a final rejection on March 2, 2026. Claim 1 is rejected as obvious over two references; dependent claim 4 is objected to as allowable if rewritten. The client wants claim 1 if it can be had, and a patent soon either way.

1. By April 15 (inside 2 months) the attorney interviews the examiner, who will not move on claim 1 because she reads the secondary reference as teaching the missing feature.
2. On April 28 the applicant files a notice of appeal ($362) with a 5-page pre-appeal request on that one factual point, and, separately, a continuation to carry claim 4's subject matter forward if needed.
3. If the panel reopens or allows, the appeal ends there. If the appeal proceeds, the applicant can still amend claim 1 to include claim 4 under 41.33(a) before the brief and take an early patent, leaving the broad claim to the continuation.

Total official fees so far: $362 for the notice, plus the continuation filing fees. No RCE fee was spent on an argument the examiner had already said she would not accept.

More USPTO guides

• How to file a provisional patent application (US)

  What a US provisional must contain, the USPTO fees, the 12-month deadline under 35 U.S.C. 119(e), and when to skip it.

• USPTO patent fees (2026)

  Every USPTO patent fee for large, small and micro entities, from filing to maintenance, with a fee calculator.

• Patent drawing requirements: USPTO, EPO and India

  37 CFR 1.84, the EPO rules that replaced Rule 46 EPC, and Indian rule 15, compared side by side.

• How to write patent claims: USPTO, EPO and India

  Claim structure and worked examples, then the claim rules and fees at the USPTO, the EPO and the Indian Patent Office, side by side.

• How to respond to a USPTO office action

  Reply deadlines and extension fees, 101, 102, 103 and 112 rejections, interviews, and options after a final rejection.

• Types of patent searches, and which one you need

  Patentability, freedom-to-operate, invalidity and landscape searches compared by purpose, timing, scope and deliverable.

• Patentability search: how to check novelty before you file

  What counts as prior art under 35 U.S.C. 102 and Art. 54 EPC, the grace period gap, search steps and how to read results.

• Freedom-to-operate search in the US and Europe

  In-force claims only, legal status checks at the USPTO, EPO and UPC, FTO opinions after Halo, and design-arounds.

• Invalidity search: prior art to challenge a patent

  IPR, PGR, EPO opposition and UPC revocation deadlines, prior art dates, standards documents and claim charts.

• Patent landscape analysis, step by step

  Building a CPC and keyword dataset, cleaning families and names, the metrics that matter and the 18-month publication lag.

• How to use USPTO Patent Public Search

  Basic and Advanced Search, the three databases, field codes, ADJ, NEAR, WITH and SAME, truncation and a worked search.

• Google Patents search guide

  Search operators and fields, Boolean and proximity syntax, non-patent literature, and where Google Patents falls short of the official databases.

• The Cooperative Patent Classification (CPC), explained

  How CPC symbols are built, CPC against IPC, the Y section, how to find the right class and how to search it in each database.

• Patent search Boolean operators and search strings

  Boolean, proximity and truncation syntax compared across Patent Public Search, Espacenet, Google Patents and The Lens, with semantic search for contrast.

• How to respond to a 35 U.S.C. 101 rejection

  The Alice/Mayo steps in MPEP 2106, Ex parte Desjardins and the 2024-2026 USPTO guidance, Berkheimer evidence and Rule 132 eligibility declarations.

• How to respond to a 35 U.S.C. 102 rejection

  Anticipation under MPEP 2131, AIA 102(a)(1) and (a)(2), the 102(b) exceptions, inherency and Rule 130 declarations.

• How to respond to a 35 U.S.C. 103 rejection

  Graham and the KSR rationales in MPEP 2143, teaching away, motivation to combine, secondary considerations with nexus, and Rule 132 evidence.

• How to respond to a 35 U.S.C. 112 rejection

  Written description and enablement after Amgen, 112(b) indefiniteness, 112(f) means-plus-function after Williamson, and 112(d) dependent claims.

• The PCT application: timeline, fees and national phase

  The international phase month by month, receiving Office and ISA fees in CHF, USD and EUR, national phase deadlines by office, and a deadline calculator.

• Entering the US national stage under 35 U.S.C. 371

  The 30-month deadline and revival, the 371 requirements, national stage fees by entity size, and 371 versus a bypass continuation.

• The US foreign filing license (35 U.S.C. 184)

  When a US-made invention needs a license to be filed abroad, the six-month rule, expedited and retroactive licenses, and the Indian and European equivalents.

• Filing a US patent from Europe or India

  The 2026 US practitioner rule for foreign applicants, Paris priority and certified copies, small entity status, PCT or direct, fees and translations.

• What is a utility patent?

  What a US utility patent covers under 35 U.S.C. 101, the parts of the application in 37 CFR 1.77 order, the 20-year term and USPTO costs.

• Design patents in the United States

  What a design patent protects, drawings and the single claim, the 15-year term, Hague filings, LKQ v. GM, and design vs utility patents.

• How to file a nonprovisional patent application

  Required parts and fees, claiming a provisional within 12 months, DOCX filing in Patent Center, and what happens after you file.

• Provisional vs nonprovisional patent application

  The two US filings side by side, the cost of each route, the effect on term and publication, and a guide to which to file.

• Continuation, CIP and divisional applications

  Copendency, patent term, double patenting and terminal disclaimers, the 2025 continuing application fee, and continuation strategy.

• How much does a patent cost?

  USPTO fees by entity size from filing to the last maintenance fee, what drives professional fees, EPO fees, and an estimator.

• How to patent an idea in the US

  Nine steps from patentability and search to provisional filing, Patent Center, examination and maintenance, with the USPTO's free help programs.

• Small entity vs micro entity status

  Who qualifies under 37 CFR 1.27 and 1.29, the 2026 income limit, SB/15A and SB/15B, license traps, fixing errors, and an eligibility checker.

• How long does a patent last?

  US utility and design terms, patent term adjustment and extension, terminal disclaimers, maintenance fee deadlines, Europe and India, with an expiry estimator.

• Can AI write a patent application?

  What AI drafting does well and badly, the USPTO and EPO positions on AI tools, AI inventorship after 2025, and confidentiality.

• Restriction requirements and election of species

  How to answer a USPTO restriction or election of species requirement, from traverse and rejoinder to divisionals and unity in 371 cases.

• Request for continued examination (RCE)

  What 37 CFR 1.114 requires, first and later RCE fees, patent term effects, and when an RCE beats an appeal.

• Information disclosure statements (IDS)

  The duty of disclosure, IDS timing windows and fees, the 2025 size fee, EPO search reports, Therasense and QPIDS.

• PTAB ex parte appeals

  Notice of appeal to decision step by step, with fees, deadlines and the PTAB's FY 2026 pendency and outcome statistics.

• Track One prioritized examination

  Track One requirements, fees by entity size, the 20,000 annual cap and USPTO timing data, plus PPH and age or health petitions.

• 35 U.S.C., annotated: US patent law section by section

  The current text of 34 key sections of Title 35 with plain-English summaries, key cases, 37 CFR rules and MPEP references.

All guides, by patent office